- Home
- Catalog
- Growth hormone axis
- Tesamorelin + Ipamorelin
peptide
Tesamorelin + Ipamorelin
Tesamorelin and ipamorelin supplied together in one vial.
Tesamorelin + Ipamorelin · 10 mg (5 + 5) · Lyophilised vial
peptide
Tesamorelin + Ipamorelin
Tesamorelin and ipamorelin supplied together in one vial.
In stock
What it is
A blend of tesamorelin (5 mg) and ipamorelin (5 mg) in a single lyophilised vial, as stated by the store. The two compounds act on different receptors (GHRH receptor and ghrelin receptor) and are often studied together in growth-hormone-axis research.
Per vial: Tesamorelin 5 mg, Ipamorelin 5 mg.
Where it has been studied
Literature search: PubMed, "tesamorelin ipamorelin". The areas listed describe published research, not outcomes.
- Combined GHRH analogue and secretagogue protocols
- Growth hormone pulsatility studies
Specifications
| Compound | Tesamorelin + Ipamorelin |
|---|---|
| Type | Peptide |
| Selected presentation | 10 mg (5 + 5) · Lyophilised vial |
| Form | Lyophilised powder in a sealed glass vial |
| Fill volume and concentration | Not applicable (lyophilised) |
| Label | CELVIVE wordmark, compound name, amount, "Purity: >99%", "For research use only" |
| Storage | -20 °C for long-term storage; 2 to 8 °C for under three months; away from light |
| Certificate of analysis | Not yet published online. Request for a batch |
| Research areas | Growth hormone axis |
| All presentations | 10 mg (5 + 5) lyophilised vial · € 90.00 |
Handling
- Lyophilised peptides tolerate room temperature for several weeks in transit. Move to cold storage on receipt.
- Reconstituted vials are typically used within three to four weeks at 2 to 8 °C; stability varies by compound.
- Opened or unsealed vials cannot be returned. Transit damage must be documented within 24 hours.





